[US Stock Market News] Procter & Gamble surged on October 22: Earnings exceeded expectations, organic growth, and guidance raised
Bitget异动解读2026/10/22 13:41Procter & Gamble October 22 Surge Interpretation
Keywords: Earnings Beat, Organic Growth, Guidance Raised
1. On October 22, 2026, Procter & Gamble announced net sales of $23.28 billion for the first quarter of fiscal year 2027, representing a year-on-year increase of about 4%. Organic sales grew by 4%, and core earnings per share reached $2.00, exceeding both last year's $1.99 and analysts' expectations of $1.88. Sales also surpassed expectations.
2. On October 22, 2026, the company raised its fiscal year 2027 sales growth forecast from 1%–3% to 2%–4%, incorporating the impact of the Thorne acquisition. At the same time, it maintained its full-year core earnings per share guidance at $6.89–$7.11 and organic sales growth guidance.
(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%
Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.
Crypto prices
More
